R. M. Lau et al. / Tetrahedron 56 (2000) 7601–7606
7605
d-Isomer: (4a, using as starting material 10.4 g of 3):
TLC one spot, Rf0.15, EtOAc–hexane (1:4); yield
10.1 g as crude extract (quantitative); [a]2D2Ϫ30.2 (c2,
CH2Cl2).
solution of compound 6 (4.6 g, 16.1 mmol) and 6-amino-
penicillanic acid allyl ester 4-toluenesulfonate (7.24 g,
16.9 mmol) in dry acetonitrile (150 ml), containing tri-
ethylamine (2.48 ml, 17.7 mmol) and a catalytic amount
of DMAP was treated with DCC (3.65 g, 17.7 mmol), set
aside at 4ЊC for 24 h and was then allowed to attain room
temperature gradually. The suspension was cooled again to
Ϫ20ЊC, filtered and the filtrate was evaporated in vacuo.
The solid residue was dissolved in pure anhydrous EtOAc
(30 ml), washed with ice-water (2×10 ml), ice-cold aqueous
0.05 M KHSO4 solution (5 ml), saturated NaHCO3 solution
(pH 7–8, 10 ml) and saturated NaCl solution (2×10 ml),
then dried (Na2SO4) and concentrated in vacuo. Column
chromatography (silica 60, EtOAc–hexane 2:1 v/v) of the
residue followed by evaporation of solvent gave the
expected compound as a white foam.
2-(N-Allyloxycarbonyl)aminoadipic acid 1-allyl ester (6).
A stirred solution of compound 4 (22.2 g, 50 mmol) in a
mixture of AcOH/water/2 M HCl (200 ml, 160:15:25
v/v/v) was heated to 60ЊC for 30 min and subsequently
cooled down to room temperature. The precipitated tri-
phenylmethanol was collected by filtration. Ether (150 ml)
and water (20 ml) were added to the filtrate. The two phases
were re-extracted, to remove triphenylmethanol completely;
the combined aqueous phases were concentrated in vacuo,
to yield pale yellow syrup of 2-aminoadipic acid 1-allyl
ester hydrochloride (5) which solidified. This product,
dissolved in a mixture of acetonitrile and water (60 ml,
4:1 v/v) was treated with triethylamine (6.2 ml, 44 mmol)
to give pH 9.3. Subsequently, a solution of allyl succini-
midyl carbonate (5.33 g, 26.8 mmol, 1.27 equiv.) in aceto-
nitrile (10 ml) was added, the apparent pH being controlled
with a pH-stat. The pH of the mixture decreased immedi-
ately and further triethylamine was added to restore the pH
to 9. The almost clear solution was filtered and concentrated
to remove organic solvent. Water (40 ml) was added and the
product was precipitated by the addition of a small excess of
1.5 M hydrochloric acid (20 ml), to give pH Ͻ2. The
decanted water phase was then extracted with ether
(4×20 ml) and the ether phases were combined with the
main product. The obtained extract of the crude product
was washed with 10% aqueous NaCl (3 times), dried
(Na2SO4) and concentrated in vacuo to leave clear syrup.
Protected isopenicillin N (7b): TLC Rf0.65, EtOAc–
hexane (2:1); yield 6.6 g (68%); purity 56%; [a]2D0ϩ144
(c1.5, CHCl3). IR (KBr): n1780 cmϪ1 (b-lactam car-
0
1
00
bonyl). H NMR (CDCl3): d1.52 (s, 3H, H2 ); 1.66 (s,
3H, H2 ); 1.74 (m, 2H, H11); 1.74–1.90 (m, 2H, H12);
2.29–2.34 (m, 2H, H10); 4.38 (m, 1H, H13); 4.44 (s, 1H,
H3); 4.58–4.67 (m, 6H, CH2vCHCH2–); 5.22–5.39 (m,
6H, CH2vCHCH2–); 5.40 (s, 1H, NH); 5.55 (d, 1H,,
J4.0 Hz, H5); 5.69 (d, 1H,, J4.0 Hz, H6); 5.91–5.92
(m, 3H, CH2vCHCH2–); 6.26 (s, 1H, NH). 13C NMR
(CDCl3): d21.5 (C-11); 27.5 (C-20); 31.9 (C-200); 32.4
(C-12); 35.5 (C-10); 53.8 (C-13); 58.9 (C-6); 65.3 (C-2);
66.4, 66.5, 66.7 (CH2vCHCH2–); 68.4 (C-5); 70.9 (C-3);
118.3, 119.5, 120.3 (CH2vCHCH2–); 131.4, 132.9, 133.0
(CH2vCHCH2); 156.2 (allyloxycarbonyl); 167.7, 172.0,
172.2 (carboxyl carbons); 174.2 (C-7).
l-Isomer (6b): TLC Rf0.8, BuOH–AcOH–water (4:1:1);
yield 12.9 g (90%); purity 75%; [a]2D0ϩ6.0 (c1, CHCl3).
1H NMR (CDCl3): d1.6–2.0 (m, 4H, H3ϩH4); 2.40 (m,
2H, H5); 4.40 (m, 1H, H2); 4.57ϩ4.65 (2×d, J5.4 Hz, 4H,
CH2vCHCH2–); 5.2–5.5 (m, 4H, CH2vCHCH2–); 5.85–
6.0 (m, 2H, CH2vCHCH2–); 6.1 (bs, 1H, NH). The acid
was crystallized as the dicyclohexylammonium salt by
dissolving the syrup in ether and adding dicyclohexylamine.
TLC two spots, Rf0.8 (acid) and 0.57 (amine), BuOH–
AcOH–Water (4:1:1); mp 117.5ЊC; [a]2D0Ϫ1.9 (c1,
CHCl3). Anal. calcd for C25H42N2O6 (466.61): C 64.35, H
9.07, N 6.00. Found: C 63.93, H 8.85, N 5.90.
Protected penicillin N (7a): starting from 2.5 g of 6a: TLC
Rf0.69, EtOAc–Hexane (2:1); yield 3.5 g (66%); purity
50%; [a]2D0ϩ87.8 (c1.5, CH2Cl2). IR (KBr):
n1780 cmϪ1 (b-lactam carbonyl).00 1H NMR (CDCl3):
0
d1.52 (s, 3H, H2 ); 1.67 (s, 3H, H2 ); 1.72–1.90 (m, 2H,
H12); 1.76 (m, 2H, H11); 2.27–2.38 (m, 2H, H10); 4.39 (m,
1H, H13); 4.44 (s, 1H, H3); 4.57–4.67 (m, 6H,
CH2vCHCH2–); 5.08–5.44 (m, 6H, CH2vCHCH2–);
5.41 (s, 1H, NH); 5.55 (d, 1H,, J4.0 Hz, H5); 5.70 (d,
1H, J4.0 Hz, H6); 5.91–5.92 (m, 3H, CH2vCHCH2–);
6.34 (s, 1H, NH). 13C NMR (CDCl3): d21.5 (C-11);
27.5 (C-20); 31.9 (C-200); 32.5 (C-12); 35.5 (C-10); 53.8
(C-13); 58.9 (C-6); 65.2 (C-2); 66.3, 66.6, 66.6
(CH2vCHCH2–); 68.5 (C-5); 70.9 (C-3); 118.3, 119.5,
d-Isomer (6a, using 3.63 g of crude 5a as starting material;
as explained in the text, this crude material contained d-2-
aminoadipic acid and was extensively purified by silicagel
chromatography using hexane–EtOAc (9:1) prior to further
reaction): TLC Rf0.75, BuOH–AcOH–Water (4:1:1);
yield 2.6 g (approx. 50% based on crude 5a); purity 70%;
[a]2D0Ϫ1.7 (c1, CH2Cl2). 1H NMR (CDCl3): d1.6–2.0
(m, 4H, H3ϩH4); 2.40 (m, 2H, H5); 4.37 (m, 1H, H2);
4.57ϩ4.65 (2×d, J5.4 Hz, 4H, CH2vCHCH2–); 5.15–
5.5 (m, 4H, CH2vCHCH2–); 5.68 (bs, 1H, NH); 5.85–6.0
(m, 2H, CH2vCHCH2–). 13C NMR (CDCl3): d21.0
(C-4); 31.6 (C-3); 33.7 (C-5); 54.1 (C-2); 66.3
120.3
(CH2vCHCH2–);
131.4,
131.8,
132.9
(CH2vCHCH2); 156.4 (allyloxycarbonyl); 167.7, 172.1,
172.2 (carboxyl carbons); 174.2 (C-7).
(Iso)penicillin N disodium salt (1). To a stirred solution of
compound 7b (2.45 g, 4.7 mmol) in peroxide-free THF
(25 ml) and maintained under argon, dimedone (3.29 g,
23.5 mmol) and tetrakis-(triphenylphosphine)palladium(0)
(0.36 g, 0.3 mmol) were added. The solution was kept for
16 h at room temperature, during which time a precipitate
was gradually formed. The solid material was collected by
filtration, washed with THF (2×5 ml), dissolved in ice-cold
water (25 ml) and the pH was carefully adjusted to 7 by
addition of an aqueous solution of 10% NaHCO3 (w/w).
The solution was extracted with EtOAc (3×5 ml), the
(CH2vCHCH2–);
119.2
(CH2vCHCH2–);
131.9
(CH2vCHCH2–); 169.3 and 176.3 (carboxyl carbons).
6-[6-(2-(N-Allyloxycarbonyl)aminoadipyl)]aminopeni-
cillanic acid diallyl ester (7). A stirred, cooled (Ϫ20ЊC)